000 01449 a2200433 4500
005 20250513063110.0
264 0 _c19940519
008 199405s 0 0 eng d
022 _a0031-6970
024 7 _a10.1007/BF00315305
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMartin, G
245 0 0 _aEffect of intravenous dopamine on blood pressure and plasma insulin in hypertensive patients.
_h[electronic resource]
260 _bEuropean journal of clinical pharmacology
_c1993
300 _a503-5 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aBlood Glucose
_xmetabolism
650 0 4 _aBlood Pressure
_xdrug effects
650 0 4 _aDopamine
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHeart Rate
_xdrug effects
650 0 4 _aHumans
650 0 4 _aHypertension
_xblood
650 0 4 _aInfusions, Intravenous
650 0 4 _aInsulin
_xblood
650 0 4 _aLabetalol
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aMetoclopramide
_xpharmacology
650 0 4 _aMiddle Aged
700 1 _aForte, P
700 1 _aLuchsinger, A
700 1 _aMendoza, F
700 1 _aUrbina-Quintana, A
700 1 _aHernandez Pieretti, O
700 1 _aRomero, E
700 1 _aVelasco, M
773 0 _tEuropean journal of clinical pharmacology
_gvol. 45
_gno. 6
_gp. 503-5
856 4 0 _uhttps://doi.org/10.1007/BF00315305
_zAvailable from publisher's website
999 _c8156357
_d8156357